EUCTR2020-002039-31-FI进行中（未招募）1 期
COVIDSTORM - study protocolCOVID-19: Slavage TOcilizumab as a Rescue Measure - COVIDSTORM
Turku University Hospitla0 个研究点目标入组 90 人开始时间: 2020年4月28日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •age > 18 years / hospitalized with COVID-19 / SpO2 Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 45
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 45
排除标准
- •allergy to monoclonals / active tbc or obvious bact infection / long-term anti-rejection or immunomodul drugs / pregnant or lactating woman / participating in other drug clinical trials
研究者
相似试验
已完成
不适用
Observational study on the evaluation of COVID-19 prevention and subjects' health status after SARS-CoV-2 vaccinatioCOVID-19JPRN-UMIN000045107Shionogi & Co., Ltd.829
招募中
Unknown
A registry study on the actual situation for COVID-19 outpatients in Japan -ANTARES STUDYCOVID-19JPRN-UMIN000052703Shionogi & Co., Ltd.10,000
已完成
不适用
Audit of Indian Clinical trials on COVID-19CTRI/2021/03/031687I1,071
进行中（未招募）
1 期
Treatments of COVID-19 in primary care in the NetherlandsCTIS2022-500678-33-00Maastricht University1,200
尚未招募
Unknown
Epidemiological study on patients with COVID-19COVID-19JPRN-UMIN000050989The Jikei University School of Medicine, Japan2,000